Company alleviates the global burden of corneal blindness through innovative solutions in eye banking and corneal transplantation News Article
Read MoreBreviTest Technologies announced that the FDA has officially accepted BreviTest’s notification of its intent to commercially distribute its IgG antibody test. The BreviTest SARS-CoV-2 IgG Test detects the presence of SARS-CoV-2 specific IgG antibodies in plasma or serum using only 3μl of sample. Reliable results are available in 10 minutes. A positive test result indicates prior […]
Read MoreCoapTech announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement. News Article
Read MoreCongratulations to all of the companies being recognized as winners of this year’s Best in Tech Awards for your work to advance Baltimore’s tech industry. The honorees, who were chosen by BBJ staff, represent the incredible, growing tech ecosystem here in Baltimore, one fueled by world-class assets, phenomenal talent and a commitment to excellence. Baltimore […]
Read MoreThe Port Covington team at Weller Development outlines how a broad array of commercial and social interests are contributing to efforts against the COVID-19 outbreak. The LaunchPort is prominently featured across a range of activities. News Article
Read More
The LaunchPort™ announced today that Brevitest Technologies will become the latest out-of-state company to partner with the device accelerator. Brevitest has developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays (ELISAs), the gold standard for measuring concentrations of molecules in solution. Unlike ELISAs done in laboratories, the technology is portable with a run […]
Read More
Baltimore engineering design firm Key Tech Inc. sets up positive pressure air respiratory assembly operation at The LaunchPort in response to requests from area hospitals. The positive pressure suits were on back order through the end of the summer, and Key Tech and Johns Hopkins collaborated to design and assemble the blower assemblies from readily available components to […]
Read MoreCompany closed round that was led by investors from San Francisco and Baltimore, allowing the Johns Hopkins spin-out to continue clinical development of its first product. LifeSprout is a LaunchPort Resident that operates clean room, wet lab and engineering cells as part of their GMP process development efforts. News Article
Read More
Company aims to develop next generation home dialysis technology. News Article
Read More
Company’s expanded sterilization capacity is first step in projected product line growth for Baltimore for neuro-implant company. News Article
Read More